We respond to SMC approval of adjuvant Perjeta for use on NHS in Scotland

The Scottish Medicines Consortium (SMC) has today (7 September 2020) approved Perjeta – given in combination with trastuzumab and chemotherapy...

7 September 2020

We respond to study suggesting single-dose radiotherapy as effective for treating breast cancer

A new study published in the BMJ suggests that asingle targeted dose of radiotherapy could be as effective at treating breast cancer as a full course...

20 August 2020

We respond to NHS England breast cancer waiting times: June 2020 and Q1 20/21

NHS England cancer waiting times data from Q1 2020/21 shows: The two week wait target for people referred with suspected breast cancer was...

14 August 2020

Breast Cancer Now responds to SMC approval of neratinib

The Scottish Medicines Consortium (SMC) has today (10 August 2020) announced its decision to approve neratinib (Nerlynx) for routine NHS use in...

10 August 2020

We respond to the NHS People Plan 2020/2021

The new NHS People Plan for 2020/2021 was launched on Thursday 30 July 2020 to address the workforce challenges the health service is currently...

30 July 2020

We respond to study suggesting delays to cancer referral and diagnosis could cost over a thousand lives

Delays to cancer referral through reduced use of the urgent GP referral pathway during the coronavirus pandemic could result in more than a thousand...

21 July 2020

We respond to announcement that Breast Screening Programme in Scotland will restart in August

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, the research and care charity, said:  “It’s encouraging to hear...

14 July 2020

We respond to NHS England breast cancer waiting times: May 2020

NHS waiting times data from May 2020 shows: The two week wait target for people referred with suspected breast cancer was met. The target is 93...

10 July 2020

We respond to NHS England breast cancer waiting times: April 2020

NHS waiting times data from April 2020 shows: The two week wait target for people referred with suspected breast cancer was missed. The target...

11 June 2020